Technology Servier and Aqemia Extend Collaboration on Undruggable Target in Immuno-Oncology AIT News Desk Jan 9, 2023 Servier and Aqemia announce the extension of their new-molecule discovery collaboration on an undruggable therapeutic target in immuno-oncology.…
Machine Learning GNS and Servier Announce AI Collaboration to Advance Multiple Myeloma Drug Discovery and Clinical… AIT News Desk Aug 24, 2022 GNS, the leader in the use of "Digital Twins" and Causal AI & biosimulation technology for biopharmaceutical drug discovery and development, and …
Business Intelligence The Servier Group Opens a Worldwide Artificial Intelligence Hub in Montreal, in Partnership With… AIT News Desk Dec 15, 2020 Servier, an international pharmaceutical company, announces the opening of a worldwide Artificial Intelligence (AI) Hub in Montreal, in partnership…
Blockchain Servier Joins Embleema’s Blockchain Health Consortium to Launch a Pilot Project for Blockchain AIT News Desk Dec 10, 2018 Servier, an independent international pharmaceutical company, announced that it has joined Embleema's Blockchain Health Consortium, a decentralized…